Financing and HSA/FSA
altRx vs Embody: Financing and HSA/FSA Compared (2026)
altRx or Embody? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 8.7 and 7.6 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put altRx and Embody side by side and the marketing reads almost identically. The programs underneath do not.
Neither of these bills insurance, so the financing question is a real one. altRx supports Affirm, Klarna and Afterpay, while Embody expects the card to clear each month.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Anything a provider declines to disclose is marked undisclosed rather than filled in.
The short answer
- Lowest 12-month cost
- Embody — $828 against $1,068 at altRx, on each provider's own best published pricing.
- Most predictable bill
- altRx — Flat rate at every dose, so titration does not change what you are charged.
- Fastest route to a first shipment
- altRx — 100% online medical visits, then free, discreet 2-day delivery.
- Easiest to pay for
- altRx — Affirm, Klarna and Afterpay.
altRx and Embody, side by side
The rows below are the ones that differ enough between these two to be worth your attention.
| altRx | Embody | |
|---|---|---|
| Advertised price | Semaglutide $89/mo, tirzepatide $149/mo | Semaglutide $69/mo (was $299), tirzepatide $119/mo |
| Rate after promotions | $89/mo | $69/mo |
| Pricing structure | Flat rate at every dose | Published rate per medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Payment options | Affirm, Klarna and Afterpay | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | 100% online medical visits | Licensed provider review handled entirely online |
| State coverage | Not available in every state | Not published |
| Price transparency | Published upfront | Published upfront |
| Patient reviews | 14,820 | 11,250 |
| eRxDoctor score | 8.7/10 | 7.6/10 |
The real cost: six months and twelve
Comparing entry prices across these two would be actively misleading, because they escalate differently. These are the totals — six months and twelve — using each provider's own published rates and best available plan.
| altRx | Embody | |
|---|---|---|
| First month | $89 | $69 |
| Months 2 onward | $89/mo | $69/mo |
| 6-month total | $534 | $414 |
| 12-month total | $1,068 | $828 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Embody finishes the year $240 cheaper. For some patients the support altRx bundles closes that gap; for a patient who only needs the prescription written, it does not.
How you pay, not just what you pay
altRx accepts Affirm, Klarna and Afterpay. Buy-now-pay-later spreads the first months, which is when GLP-1 costs and side effects both peak.
Embody publishes no financing options, so the full monthly charge lands on a card each cycle. At $69/mo that is manageable for most people, but it removes a lever if a month gets tight.
Check whether the financing applies to multi-month plans or only to a single order. That detail decides whether it helps in month seven as well as month one.
How altRx works
altRx is the most affordable GLP-1 program, limited offer: semaglutide $89/month and tirzepatide $149/month. 100% online medical visits, no membership, insurance or hidden fees, free and discreet 2-day delivery. What it is really selling here is the cheapest published tirzepatide rate on this list at $149, with the injection kit included.
You start with 100% online medical visits; medication arrives via free, discreet 2-day delivery. The price behaves as flat rate at every dose.
On the clinical side, responsive care team for ongoing clinician-guided support, prescribing compounded semaglutide and compounded tirzepatide.
altRx pros
- No commitment, cancel anytime
- Free and discreet 2-day delivery
- Responsive care team for ongoing clinician-guided support
- Complete treatment kit: vials, syringes, prep pads, and step-by-step guidance
altRx cons
- Not available in all U.S. states
- Compounded medication, not FDA-approved branded product
The reservation worth holding, particularly next to Embody: the rate is a limited offer and the platform does not operate in every state.
Embody in detail
Semaglutide $69/mo (was $299), Tirzepatide $119/mo In this pairing, its distinguishing feature is the lowest published semaglutide price on this list, with no lock-in.
The process is licensed provider review handled entirely online, then free shipping, 1-2 day delivery after approval. On money, expect published rate per medication — published upfront.
Behind the prescription sits 24/7 support for dosing and side-effect questions. Available medication: compounded semaglutide and compounded tirzepatide.
Embody pros
- Compounded tirzepatide available at $119/month
- Lowest entry price on this list at $69/month for compounded semaglutide
- No long-term commitment; cancel without penalty
- Free shipping with fast 1–2 day delivery after approval
Embody cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Final pricing may vary based on dose and clinician recommendation
Read next to altRx, the weak point: a limited-time rate with few of the extras that higher-priced platforms bundle.
altRx or Embody: matching the program to the patient
Choose altRx if:
- the level of clinical contact suits you: responsive care team for ongoing clinician-guided support
- what it leads on is worth paying for in your case: the cheapest published tirzepatide rate on this list at $149, with the injection kit included
- you need to spread the cost — Affirm, Klarna and Afterpay
- you want the price you sign up at to survive titration
Choose Embody if:
- the monthly rate is the constraint — $69/mo against $89/mo
- the twelve-month total is what you are optimizing ($828 against $1,068)
- you would get real value from the lowest published semaglutide price on this list, with no lock-in
- the level of clinical contact suits you: 24/7 support for dosing and side-effect questions
Where each program concedes something
On price. The monthly gap is 29% in Embody's favor. Whether that is a saving or a false economy turns on one thing: a limited-time rate with few of the extras that higher-priced platforms bundle.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Financing is available through altRx (Affirm, Klarna and Afterpay).
On clinical contact. Responsive care team for ongoing clinician-guided support at altRx; 24/7 support for dosing and side-effect questions at Embody. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
On medication. altRx covers compounded semaglutide and compounded tirzepatide; Embody covers compounded semaglutide and compounded tirzepatide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
What the trials and the FDA say
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
altRx vs Embody: common questions
What happens when altRx's promotional price ends?
The rate moves to $89/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which is cheaper to start, altRx or Embody?
Embody, at $69 against $89. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which has more patient reviews, altRx or Embody?
altRx, with 14,820 against 11,250. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Are altRx and Embody legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. altRx operates on flat rate at every dose with pricing published upfront, Embody on published rate per medication, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
Is altRx or Embody better for a first GLP-1 prescription?
For a first prescription, weight support over price. altRx offers more contact (responsive care team for ongoing clinician-guided support), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
The verdict
Embody is the cheaper year by $240, and for a straightforward course of treatment that settles it.
Where altRx justifies itself is the cheapest published tirzepatide rate on this list at $149, with the injection kit included. Where it does not is anywhere the extra spend buys features you will never open.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- altRx vs MaximusTirzepatide access
- altRx vs He & She MDBudget vs premium
- Refills vs EmbodyBudget vs premium
- Gala vs EmbodyBudget vs premium
- Yucca Health vs Elevate HealthFinancing and HSA/FSA
- Yucca Health vs NoviFinancing and HSA/FSA
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by altRx or Embody, and does not sell treatment. Read our ranking methodology.